These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tobacco company set up network of sympathetic scientists. Dyer C. BMJ; 1998 May 23; 316(7144):1555. PubMed ID: 11645059 [No Abstract] [Full Text] [Related]
24. Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry. Iida K, Proctor RN. Lancet; 2004 May 29; 363(9423):1820-4. PubMed ID: 15172783 [Abstract] [Full Text] [Related]
25. Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. Fields N, Chapman S. J Epidemiol Community Health; 2003 Aug 29; 57(8):571-8. PubMed ID: 12883059 [Abstract] [Full Text] [Related]
29. 'It's interesting how few people die from smoking': tobacco industry efforts to minimize risk and discredit health promotion. Smith EA. Eur J Public Health; 2007 Apr 29; 17(2):162-70. PubMed ID: 16837518 [Abstract] [Full Text] [Related]
31. Human lung cancer and p53: the interplay between mutagenesis and selection. Rodin SN, Rodin AS. Proc Natl Acad Sci U S A; 2000 Oct 24; 97(22):12244-9. PubMed ID: 11035769 [Abstract] [Full Text] [Related]
34. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. White J, Parascandola M, Bero L. Nicotine Tob Res; 2007 Nov 24; 9(11):1213-25. PubMed ID: 17978997 [Abstract] [Full Text] [Related]
36. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA. JAMA; 1995 Jul 19; 274(3):241-7. PubMed ID: 7609233 [Abstract] [Full Text] [Related]